COLLAGEN SOLUTIONS P

COS
End-of-day quote. End-of-day quote  - 11/16
6.625GBX 0.00%

Collagen : Acquired by Rosen's Diversified, Inc.

10/20/2020 | 04:10am

Collagen Solutions Plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that today Rosen's Diversified, Inc. ('RDI') declared that its offer to acquire Collagen Solutions plc (the 'Offer') had become wholly unconditional and as a result, Collagen Solutions will become part of the RDI Group.

RDI is a multi-billion dollar, family-owned and controlled business, headquartered in Minnesota near the Company's U.S. offices. RDI sells a broad range of food, agricultural and scientific products into more than 30 countries, across five continents, and has over 4,500 employees. Collagen Solutions will become part of RDI's life sciences division, which includes Scientific Life Solutions ('SLS'), a supplier of critical components to the bioresearch and biomedical fields.

Jamal Rushdy, CEO of Collagen Solutions said: 'We have made tremendous progress in our vision to be the industry's first choice for regenerative biomaterials. We believe that being part of RDI will generate significant growth opportunities and create enhanced value for the benefit of all stakeholders and in particular our employees, customers and suppliers. I am optimistic and excited for the potential for continued momentum and greater opportunity for Collagen Solutions.'

Wade Rosen, Director of RDI and Executive Vice President of Corporate Development of SLS said: 'Collagen Solutions represents an attractive strategic and cultural fit with SLS and we have been highly impressed by the long-term vision and ethos of the Company. The successful completion of the Offer will now provide a foundation for SLS to become a major tissue provider in North America, leveraging the RDI Group's local porcine and bovine harvest, logistics and distribution capabilities in the United States. Collagen's international presence will also provide a platform for SLS to extend its supply of porcine and bovine tissue into the EMEA and APAC regions.'

England & Company, LLC and Goodbody Stockbrokers UC acted, in relation to the Offer, as joint financial advisers to Collagen Solutions. Shepherd and Wedderburn LLP acted as legal adviser to Collagen Solutions.

Strand Hanson and Faegre Drinker acted, in relation to the Offer, as sole financial adviser and legal adviser to RDI, respectively.

Enquiries:

Collagen Solutions Plc
Jamal Rushdy, CEO
Hilary Spence, CFO
via Walbrook
England & Company LLC
(Joint Financial Adviser to Collagen Solutions Plc)
Craig England
Paul Teitelbaum
Tel: +1 (212) 235-0850
Goodbody Stockbrokers UC
(Rule 3 Adviser and Joint Financial Adviser to Collagen Solutions Plc)
Stephen Kane
Christopher McAuliffe
Tel: +353 (0) 1 667 0400
Cenkos Securities plc
(Nominated Adviser and Broker to Collagen Solutions Plc)
Giles Balleny
Max Gould
Tel: +44 (0) 207 397 8900
Walbrook PR Ltd
(Financial PR adviser to Collagen Solutions Plc)
Anna Dunphy
Tel: +44 (0) 207 933 8780
or [email protected]
Mob: +44 (0) 7876 741 001
Rosen's Diversified, Inc.
David Krawitz, Director of Strategy, Operations and Sales
Tel: +1 (612) 406-5181
Strand Hanson Limited
(Financial Adviser to Rosen's Diversified, Inc.)
Stuart Faulkner
Matthew Chandler
James Dance
Jack Botros
Tel: +44 (0) 207 409 3494

Important Notice

England & Company LLC, through its wholly owned subsidiary, England Securities, LLC, is acting as joint financial adviser to Collagen and no-one else in connection with the Offer and other matters described in this announcement and will not be responsible to anyone other than Collagen for providing the protections afforded to clients of England & Company LLC nor for providing advice in relation to the Offer, the contents of this announcement or any other matter referred to herein. Neither England & Company LLC nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of England & Company LLC in connection with this announcement, any statement contained herein or otherwise.

Goodbody Stockbrokers UC, trading as Goodbody, which is regulated in Ireland by the Central Bank of Ireland and in the UK by the Financial Conduct Authority, is acting as sole Rule 3 adviser and joint financial adviser to Collagen and no-one else in connection with the Offer and other matters described in this announcement and will not be responsible to anyone other than Collagen for providing the protections afforded to clients of Goodbody Stockbrokers UC nor for providing advice in relation to the Offer, the contents of this announcement or any other matter referred to herein. Neither Goodbody Stockbrokers UC nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Goodbody Stockbrokers UC in connection with this announcement, any statement contained herein or otherwise.

Cenkos Securities plc, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively as nominated adviser and broker to Collagen and no-one else in connection with the Offer and other matters described in this announcement and will not be responsible to anyone other than Collagen for providing the protections afforded to clients of Cenkos Securities plc nor for providing advice in relation to the Offer, the contents of this announcement or any other matter referred to herein. Neither Cenkos Securities plc nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Cenkos Securities plc in connection with this announcement, any statement contained herein or otherwise.

Disclaimer

Collagen Solutions plc published this content on 20 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 October 2020 08:09:10 UTC

© Publicnow 2021
Copier lien
All news about COLLAGEN SOLUTIONS PLC
01/12
12/22
12/08
12/08
11/17